Holen Sie sich die Stockscreener-App
164.36
0.40%
0.66
Handel nachbörslich:
164.81
0.45
+0.27%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt JNJ?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$163.70
Offen:
$163.77
24-Stunden-Volumen:
8.20M
Relative Volume:
1.00
Marktkapitalisierung:
$395.46B
Einnahmen:
$90.63B
Nettoeinkommen (Verlust:
$22.66B
KGV:
17.58
EPS:
9.35
Netto-Cashflow:
$18.57B
1W Leistung:
+4.81%
1M Leistung:
+9.73%
6M Leistung:
+10.94%
1J Leistung:
+6.25%
1-Tages-Spanne:
$162.78
$164.91
1-Wochen-Bereich:
$154.80
$166.12
52-Wochen-Spanne:
$140.68
$169.90
Johnson Johnson Stock (JNJ) Company Profile
Firmenname
Johnson Johnson
Sektor
Telefon
732-524-2455
Adresse
ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ
Vergleichen Sie JNJ mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
JNJ
Johnson Johnson
|
164.36 | 377.32B | 90.63B | 22.66B | 18.57B | 9.35 |
|
LLY
Lilly Eli Co
|
762.18 | 717.60B | 49.00B | 11.11B | -1.27B | 12.29 |
|
ABBV
Abbvie Inc
|
184.85 | 338.30B | 57.37B | 4.20B | 15.39B | 2.35 |
|
NVS
Novartis Ag Adr
|
114.14 | 234.32B | 55.19B | 13.65B | 16.81B | 6.86 |
|
NVO
Novo Nordisk Adr
|
64.92 | 306.33B | 43.59B | 15.04B | 10.74B | 3.3766 |
Johnson Johnson Stock (JNJ) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-13 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-12-10 | Fortgesetzt | BofA Securities | Neutral |
| 2024-11-15 | Eingeleitet | Wolfe Research | Outperform |
| 2024-07-23 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2024-05-30 | Fortgesetzt | Goldman | Neutral |
| 2024-04-18 | Hochstufung | HSBC Securities | Hold → Buy |
| 2023-12-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-12-01 | Hochstufung | UBS | Neutral → Buy |
| 2023-10-05 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-09-06 | Eingeleitet | HSBC Securities | Hold |
| 2023-05-30 | Fortgesetzt | Citigroup | Buy |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-03-01 | Eingeleitet | Guggenheim | Neutral |
| 2022-11-18 | Eingeleitet | Credit Suisse | Neutral |
| 2022-10-18 | Eingeleitet | Barclays | Equal Weight |
| 2022-10-14 | Bestätigt | BofA Securities | Neutral |
| 2022-06-22 | Eingeleitet | Daiwa Securities | Outperform |
| 2022-05-23 | Fortgesetzt | SVB Leerink | Outperform |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-03-16 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
| 2021-12-17 | Eingeleitet | Goldman | Neutral |
| 2021-12-15 | Bestätigt | Citigroup | Buy |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-05-28 | Fortgesetzt | Morgan Stanley | Overweight |
| 2020-04-28 | Herabstufung | UBS | Buy → Neutral |
| 2020-04-22 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2019-12-19 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2019-12-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-11-20 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-10-16 | Hochstufung | Atlantic Equities | Underweight → Neutral |
| 2019-10-11 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2019-07-12 | Fortgesetzt | Credit Suisse | Outperform |
| 2019-05-28 | Eingeleitet | Goldman | Buy |
| 2019-01-23 | Bestätigt | Barclays | Equal Weight |
| 2018-07-12 | Hochstufung | Goldman | Sell → Neutral |
| 2018-06-27 | Eingeleitet | Bernstein | Mkt Perform |
| 2018-04-23 | Bestätigt | Citigroup | Neutral |
| 2018-04-18 | Bestätigt | Stifel | Hold |
| 2018-01-24 | Bestätigt | Stifel | Hold |
| 2018-01-12 | Bestätigt | Wells Fargo | Outperform |
| 2018-01-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2017-10-18 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-10-18 | Bestätigt | Stifel | Hold |
Alle ansehen
Johnson Johnson Aktie (JNJ) Neueste Nachrichten
Johnson & Johnson (JNJ)’s Pasritamig Shows Breakthrough Promise in Prostate Cancer - Yahoo.co
Parks and Recreation City of Fairfax, VA - City of Fairfax (.gov)
J&J submits icotrokinra NDA for plaque psoriasis in patients 12 years and up - Contemporary Pediatrics
Master Watershed Steward Rose Johnson brings a green thumb to Philadelphia - Penn State University
Johnson & Johnson (JNJ): I Counted 15 Separate Surprises,” Says Jim Cramer - Yahoo.co
Flau'jae Johnson and Caitlin Clark are building a special bond rooted in mutual respect and basketball brilliance - MARCA
Johnson confirms: No vote on Epstein before recess - Politico
What Bees Can Teach Us About Survival and Well-being - Civil Eats
Film room: Freshman Anna Wikstrom immediately bolsters Duke's scoring and guard depth - dukechronicle.com
The biggest red flag in a job interview, according to a founder—and what impresses her most - CNBC
Trade Alert: Executive Vice President of Innovative Medicine Of Johnson & Johnson John Reed Has Sold Stock - simplywall.st
10 Magnificent S&P 500 Dividend Stocks Down Over 10% to Buy and Hold Forever - The Motley Fool
Jets Place Jermaine Johnson and Irv Charles on Active/PUP - New York Jets
Jaylon Johnson and three others on active non-football injury list - Sports Illustrated
Outdoor Indigenous museum in Yukon celebrates 30 years - CBC
NFL news roundup: Bears place CB Jaylon Johnson on NFI list; Saints sign DE Jonathan Bullard - NFL.com
Obituary | Sheila Jean Johnson of Glidden, Iowa - dahnandwoodhouse.com
Johnson & Johnson’s (JNJ) Dividend Track Record: Reliability in Uncertain Times - Yahoo Finance
Johnson & Johnson - Britannica
Jimmy Johnson gives his "No. 1 key" for Schotty & Cowboys in 2025 - Dallas Cowboys
J&J Talc Creditor Firms Decry Judge’s Failure to Address Fees - Bloomberg Law News
Emory research team helps uncover early Alzheimer’s risk markers in adults with Down syndrome - Emory News Center
Breakdown of Bengals 2025 Player Personnel Staff Shows Experience and Versatility - Cincinnati Bengals
Johnson & Johnson price target raised to $167 from $164 at Guggenheim - Yahoo Finance
2025 NBA summer league superlatives: Promising rookies, impactful veterans - ESPN
Johnson & Johnson’s TAR-200 granted FDA priority review to treat bladder cancer - PMLiVE
How bipartisan support for public media unraveled in the Trump era - NPR
Guggenheim Maintained a Hold Rating on Johnson & Johnson (JNJ) - Yahoo Finance
Current Epidemic Trends (Based on Rt) for States | CFA: Modeling and Forecasting - Centers for Disease Control and Prevention | CDC (.gov)
Moesha Johnson holds off Taddeucci once more in the 5km - World Aquatics
Congress rolls back $9 billion in public media funding and foreign aid - NPR
Scoop: House Democrats shrug off delay tactics to stall Mike Johnson's DOGE vote - Axios
Republicans plot endgame on rescissions package — and Epstein files - Politico
Moesha Johnson wins back-to-back world titles after thrilling sprint - Australian Broadcasting Corporation
House GOP closes in on Epstein measure amid rebellion - Politico
Jim Cramer explains why Johnson & Johnson rallied after 'surprise' earnings results - CNBC
Watch These Johnson & Johnson Price Levels After Stock's Post-Earnings Pop - Investopedia
Crypto bills advance after record stalemate in GOP HouseABC News - ABC News - Breaking News, Latest News and Videos
Former HSBC trader has fraud conviction overturned - BBC
Looming Epstein vote has Republicans eager to leave Washington - Politico
40-year-old sold her company for $22 million—2 years later she bought it back and is launching a 'Coachella for career women' - CNBC
Johnson & Johnson receives U.S. FDA Priority Review for TAR-200 NDA in high-risk non-muscle invasive bladder cancer - Johnson & Johnson
NASA Program Builds Bridge From Military to Civilian Careers for Johnson Team Members - NASA (.gov)
Brutal day ahead for Johnson - Politico
Obituary for John K. Larson at Johnson Funeral Home - Johnson Funeral Home Waconia, MN
City Council upholds Mayor Brandon Johnson's veto of "snap curfew" ordinance - CBS News
Bussiere, Bratton Tapped For Air Force and Space Force Vice Chief Roles - Air & Space Forces Magazine
Johnson & Johnson Earnings: Surpassing Expectations Across the Board - Morningstar
S&P 500 Gains and Losses Today: Johnson & Johnson Stock Jumps; Universal Health Services Shares Slide - Investopedia
Stock Movers: Johnson & Johnson, Ford, United Airlines - Bloomberg
Johnson & Johnson executive predicts Tremfya will be a '$10 billion dollar drug' - Fox Business
Finanzdaten der Johnson Johnson-Aktie (JNJ)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.33%
0.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):